Abstract:Background: Gliomas can be classified into five molecular subgroups based on the status of IDH mutation, 1p/19q codeletion, and TERT promoter mutation, whereas they need to be obtained by biopsy or surgery. We aimed to use MRI-based radiomic approach to noninvasively predict the five molecular subgroups and assess its prognostic value in glioma. Methods: We retrospectively identified 357 patients with grade II-IV gliomas. We extracted radiomic features of tumor and/or edema from preoperative MRI. Features were selected using the least absolute shrinkage and selection operator (LASSO). The predictive model was developed by incorporating preoperative clinical data into the multiparametric MR radiomic signature constructed by machine learning. We compared the prognostic value of predictive molecular subgroups with actual molecular subgroups in predicting progression-free survival (PFS) and overall survival (OS). We developed prognostic nomograms to predict PFS and OS of patients. Findings: Age, tumor location, and LASSO-based multiparametric MR radiomic model yielded the highest performance in predicting IDH mutation status (AUC = 0.855). Decision tree-based multiparametric MR radiomic model performed the best in predicting 1p/19q codeletion (AUC = 0.796) and TERT promoter mutation (AUC = 0.849). The predictive molecular subgroups were comparable to actual molecular subgroups in predicting PFS (C-index: 0.710 vs 0.717, P = 0.890) and OS (C-index: 0.707 vs 0.720, P = 0.630). The prognostic nomograms yielded a C-index of 0.742 and 0.747 in predicting PFS and OS, respectively. Interpretation: Multiparametric MRI-based radiomics with machine learning can be useful for noninvasively detecting molecular subgroups and predicting survival in gliomas.Funding Statement: This work was supported by the National Natural Science Foundation of China (No: 81571664, 81871323, 81801665, 81702465 and U1804172); the National Natural Science Foundation of Guangdong Province (No: 2018B030311024); the Scientific Research General Project of Guangzhou Science Technology and Innovation Commission (No: 201707010328); the China Postdoctoral Science Foundation (No: 2016M600145), the Science and Technology Program of Henan Province (No: 182102310113, 192102310050 and 192102310123), and the Youth Innovation Fund of The First Affiliated Hospital of Zhengzhou University to Zhen-yu Zhang, the Key Research Projects of Henan Higher Education (No: 18A310033). Declaration of Interests: The authors declared no competing interest exists.Ethics Approval Statement: The institutional review board in all participating centers approved this retrospective study and waived the need to obtain written consent.

Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi‐institutional Study

Quantitative MRI-based Radiomics for Noninvasively Predicting Molecular Subtypes and Survival in Glioma Patients

Radiomics Nomogram Building from Multiparametric MRI to Predict Grade in Patients with Glioma: A Cohort Study

Non-Invasive Prediction of Survival Time of Midline Glioma Patients Using Machine Learning on Multiparametric MRI Radiomics Features

Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma

Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma

Comparison of Radiomics Analyses Based on Different Magnetic Resonance Imaging Sequences in Grading and Molecular Genomic Typing of Glioma.

Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma

Radiogenomics to characterize the immune-related prognostic signature associated with biological functions in glioblastoma

Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics

A Multiparameter Radiomic Model for Accurate Prognostic Prediction of Glioma

Elaboration of Multiparametric MRI‐Based Radiomics Signature for the Preoperative Quantitative Identification of the Histological Grade in Patients with Non‐Small‐Cell Lung Cancer

Prediction of Glioma Grade Using Intratumoral and Peritumoral Radiomic Features From Multiparametric MRI Images

Predicted disease compositions of human gliomas estimated from multiparametric MRI can predict endothelial proliferation, tumor grade, and overall survival

Multiple Survival Outcome Prediction of Glioblastoma Patients Based on Multiparametric MRI

Nimg-79. A Radiomic-Risk Score For Survival Prediction In Glioma: A Large Multi-Institutional Retrospective Validation Study

Radiomics Strategy for Molecular Subtype Stratification of Lower-Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI.

Radiomic Prediction of CCND1 Expression Levels and Prognosis in Low-grade Glioma Based on Magnetic Resonance Imaging

MRI Radiomics-Based Molecular Subgrouping and Survival Prediction in Glioma Patients

Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma

A novel image signature-based radiomics method to achieve precise diagnosis and prognostic stratification of gliomas